speb/financial-data huggingface dataset:
Financial ratios for GAUZ — annual report dated 2024-12-31
Total revenue: 28363561.643835615
Gross profit: 8148219.178082192
Operating income: -8434246.575342465
Net income: -14570410.95890411
Capital expenditures: 3138356.164383562
Operating cash flow: -8741095.89041096
Depreciation & amortization: 1829041.095890411
Net tangible assets: 2391780.821917808
Owner earnings: -15879726.027397262
Return on net tangible assets (%): -663.9289805269188
Buffett classification: The Gruesome
Stock price: 9.91
Shares outstanding: 18743137
Book value: 13241095.890410963
P/B ratio: 14.027878750165524
Market cap (USD): 185744487.67000002
Debt to equity: 1.0008897165321744
Current ratio: 0.9626286842476379
Quick ratio: 0.6827668876040052
Interest coverage ratio: -2.672541019185693
COGS to revenue (%): 71.27222850077757
R&D to revenue (%): 16.990736716025772
SG&A to revenue (%): 37.022226085948596
Free cash flow (dilution-adjusted): -13733698.630136987
Buyback yield (%): 0
Retained earnings: -61647123.28767123
Inventory turnover: 4.647644242882339
Receivables turnover: 4.250225798505625
Capitalized R&D asset: 8932231.949595096
ROCI (R&D-adjusted, %): -25.12276906494994
Rosenberg metric: 0.5959185172845363
FCF margin (%): -48.420218880098915
Revenue growth (%): 31.669778341478484
Rule of 40 score: -16.75044053862043
Financial ratios for GAUZ — quarterly report dated 2024-12-31
Total revenue: 8529041.09589041
Gross profit: 3113972.602739726
Operating income: -1220547.9452054794
Net income: -3109863.01369863
Capital expenditures: 1249041.095890411
Operating cash flow: -418082.19178082194
Depreciation & amortization: 539452.0547945206
Net tangible assets: 2391780.821917808
Owner earnings: -3819452.05479452
Return on net tangible assets (%): -159.69072164948452
Buffett classification: The Gruesome
Stock price: 9.91
Shares outstanding: 18743137
Book value: 13241095.890410963
P/B ratio: 14.027878750165524
Market cap (USD): 185744487.67000002
Debt to equity: 1.0008897165321744
Current ratio: 0.9626286842476379
Quick ratio: 0.6827668876040052
Interest coverage ratio: -1.700381679389313
COGS to revenue (%): 63.489769040506246
R&D to revenue (%): 14.326555523433235
SG&A to revenue (%): 31.5858790273361
Free cash flow (dilution-adjusted): -2286575.3424657537
Buyback yield (%): 0
Retained earnings: -61647123.28767123
Inventory turnover: 1.2449609473418999
Receivables turnover: 1.278060596108055
Capitalized R&D asset: 2058150.2406516103
ROCI (R&D-adjusted, %): -3.3699017489704253
Rosenberg metric: 1.28923746863079
FCF margin (%): -26.80928977546498
Revenue growth (%): 35.684289512402266
Rule of 40 score: 8.874999736937287
Financial ratios for GAUZ — quarterly report dated 2025-03-31
Total revenue: 6061517.6151761515
Gross profit: 1553387.5338753387
Operating income: -2355826.5582655827
Net income: -2920867.2086720867
Capital expenditures: 465853.6585365854
Operating cash flow: -152574.52574525744
Depreciation & amortization: 569105.6910569106
Net tangible assets: -333875.33875338756
Owner earnings: -2817615.176151762
Buffett classification: The Gruesome
Stock price: 8
Shares outstanding: 18743137
Book value: 10543089.430894308
P/B ratio: 14.222121227637263
Market cap (USD): 149945096
Debt to equity: 1.2115463705531566
Current ratio: 0.811175025853154
Quick ratio: 0.5298765511892451
Interest coverage ratio: -4.623936170212766
COGS to revenue (%): 74.3729601645281
R&D to revenue (%): 15.455805427638932
SG&A to revenue (%): 41.874189654401576
Free cash flow (dilution-adjusted): -861788.6178861789
Buyback yield (%): 0
Retained earnings: -63899728.99728997
Inventory turnover: 0.9555402378080303
Receivables turnover: 1.0125854497713793
Capitalized R&D asset: 2167416.9757462107
ROCI (R&D-adjusted, %): -11.685396181543918
Rosenberg metric: -1.2771604263127834
FCF margin (%): -14.21737380963026
Revenue growth (%): -28.93084290452297
Rule of 40 score: -43.14821671415323
Financial ratios for GENM.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8110236220472441
Shares outstanding: 322722573
Market cap (USD): 261735630.07086614
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENM.TO — annual report dated 2022-12-31
Total revenue: 0
Operating income: -39869301.47058823
Net income: -41348272.794117644
Capital expenditures: 29842.647058823528
Operating cash flow: -22663878.676470585
Depreciation & amortization: 1253259.5588235294
Net tangible assets: -17718835.294117644
Owner earnings: -40124855.88235294
Buffett classification: The Gruesome
Stock price: 0.5735294117647058
Shares outstanding: 322722573
Book value: -17718835.294117644
Market cap (USD): 185090887.45588234
Debt to equity: -0.13697865382202123
Current ratio: 2.5484035008323516
Quick ratio: 2.5484035008323516
Interest coverage ratio: -230.23234583522637
Free cash flow (dilution-adjusted): -23618601.470588233
Buyback yield (%): 0
Retained earnings: -71195061.76470588
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -321.0726412991118
Rule of 40 score: 0
Financial ratios for GENM.TO — annual report dated 2023-12-31
Total revenue: 0
Operating income: -14560589.393939393
Net income: -13457012.878787879
Capital expenditures: 477272.72727272724
Operating cash flow: -12170040.15151515
Depreciation & amortization: 1136925
Net tangible assets: -22264434.09090909
Owner earnings: -12797360.606060605
Buffett classification: The Gruesome
Stock price: 0.17424242424242425
Shares outstanding: 322722573
Book value: -22264434.09090909
Market cap (USD): 56231963.477272734
Debt to equity: -0.08664624205482226
Current ratio: 3.488431023251874
Quick ratio: 3.488431023251874
Interest coverage ratio: -50.413321512506286
Free cash flow (dilution-adjusted): -12989918.939393938
Buyback yield (%): 0
Retained earnings: -86809500.75757575
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -124.5627531277471
Rule of 40 score: 0
Financial ratios for GENM.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.17037037037037037
Shares outstanding: 322722573
Market cap (USD): 54982364.28888889
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENM.TO — annual report dated 2024-12-31
Total revenue: 0
Operating income: -8088447.552447553
Net income: -15118965.034965036
Capital expenditures: 16445.454545454548
Operating cash flow: -7118637.062937063
Depreciation & amortization: 264831.46853146853
Net tangible assets: -34811924.47552448
Owner earnings: -14870579.020979023
Buffett classification: The Gruesome
Stock price: 0.1118881118881119
Shares outstanding: 322722573
Book value: -34811924.47552447
Market cap (USD): 36108819.356643364
Debt to equity: -0.03234246636652034
Current ratio: 2.0300287856903663
Quick ratio: 2.0300287856903663
Interest coverage ratio: -40.16738610278618
Free cash flow (dilution-adjusted): -7993908.391608393
Buyback yield (%): 0
Retained earnings: -95250811.88811189
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -214.46477628057937
Rule of 40 score: 0
Financial ratios for GENM.TO — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -1001813.2867132868
Net income: -2646068.5314685316
Capital expenditures: 0
Operating cash flow: -928440.5594405595
Depreciation & amortization: 29136.363636363636
Net tangible assets: -34811924.47552448
Owner earnings: -2616932.167832168
Buffett classification: The Gruesome
Stock price: 0.1118881118881119
Shares outstanding: 322722573
Book value: -34811924.47552447
Market cap (USD): 36108819.356643364
Debt to equity: -0.03234246636652034
Current ratio: 2.0300287856903663
Quick ratio: 2.0300287856903663
Interest coverage ratio: -23.208155132192847
Free cash flow (dilution-adjusted): -1023210.4895104895
Buyback yield (%): 0
Retained earnings: -95250811.88811189
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.56302844479254
Rule of 40 score: 0
Financial ratios for GENM.TO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1218125.8741258741
Net income: -4090226.5734265735
Capital expenditures: 0
Operating cash flow: -1271101.3986013986
Depreciation & amortization: 32303.496503496506
Net tangible assets: -38815104.8951049
Owner earnings: -4057923.076923077
Buffett classification: The Gruesome
Stock price: 0.1188811188811189
Shares outstanding: 322722573
Book value: -38815104.89510489
Market cap (USD): 38365620.56643357
Debt to equity: -0.025402247701132863
Current ratio: 1.5839036769618604
Quick ratio: 1.5839036769618604
Interest coverage ratio: -31.440329218106996
Free cash flow (dilution-adjusted): -1358147.5524475523
Buyback yield (%): 0
Retained earnings: -99341038.46153846
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -61.899741267098285
Rule of 40 score: 0
Financial ratios for GENM.TO — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1803473.722627737
Net income: -3877871.532846715
Capital expenditures: 0
Operating cash flow: -743899.2700729927
Depreciation & amortization: 29483.211678832115
Net tangible assets: -35988964.23357664
Owner earnings: -3848388.3211678825
Buffett classification: The Gruesome
Stock price: 0.23357664233576642
Shares outstanding: 322722573
Book value: -35988964.23357664
Market cap (USD): 75380455.00729927
Debt to equity: -0.024434923593061708
Current ratio: 4.412753155124995
Quick ratio: 4.412753155124995
Interest coverage ratio: -51.66573961774915
Free cash flow (dilution-adjusted): -1298115.3284671532
Buyback yield (%): 0
Retained earnings: -103617605.83941606
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.155793128692242
Rule of 40 score: 0
Financial ratios for GENM.TO — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -2137901.459854014
Net income: -11344129.927007299
Capital expenditures: 0
Operating cash flow: -1526449.6350364962
Depreciation & amortization: 47517.518248175176
Net tangible assets: -51254943.06569342
Owner earnings: -11296612.408759125
Buffett classification: The Gruesome
Stock price: 0.5985401459854014
Shares outstanding: 322722573
Book value: -51254943.06569342
Market cap (USD): 193162415.95620435
Debt to equity: -0.018298295658775842
Current ratio: 3.1942150710282875
Quick ratio: 3.1942150710282875
Free cash flow (dilution-adjusted): -2213800
Buyback yield (%): 0
Retained earnings: -119920959.12408759
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.287535082865006
Rule of 40 score: 0
Financial ratios for GENM.TO — annual report dated 2025-12-31
Total revenue: 0
Operating income: -6690289.781021898
Net income: -24719353.28467153
Capital expenditures: 0
Operating cash flow: -4722297.810218978
Depreciation & amortization: 135553.28467153283
Net tangible assets: -51254943.06569342
Owner earnings: -24583799.999999996
Buffett classification: The Gruesome
Stock price: 0.5985401459854014
Shares outstanding: 322722573
Book value: -51254943.06569342
Market cap (USD): 193162415.95620435
Debt to equity: -0.018298295658775842
Current ratio: 3.1942150710282875
Quick ratio: 3.1942150710282875
Interest coverage ratio: -51.32745151842664
Free cash flow (dilution-adjusted): -6171056.934306569
Buyback yield (%): 0
Retained earnings: -119920959.12408759
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -101.03972052763746
Rule of 40 score: 0
Financial ratios for HEMO.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.10135135135135134
Shares outstanding: 6799961
Market cap (USD): 689185.2364864864
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEMO.L — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -2646773.493975904
Operating income: -6663237.34939759
Net income: -4794354.21686747
Capital expenditures: 516801.20481927716
Operating cash flow: -3506751.807228916
Depreciation & amortization: 679604.8192771084
Net tangible assets: 3414379.5180722894
Owner earnings: -4631550.602409638
Return on net tangible assets (%): -135.648382902219
Buffett classification: The Gruesome
Stock price: 0.06385542168674699
Shares outstanding: 6799961
Book value: 3907855.421686747
P/B ratio: 0.1111132143473757
Market cap (USD): 434214.37710843375
Debt to equity: 1.0552840740923441
Current ratio: 3.4670548669113628
Quick ratio: 3.4670548669113628
Interest coverage ratio: -167590.51515151514
Free cash flow (dilution-adjusted): -4044727.7108433736
Buyback yield (%): 0
Retained earnings: -20619344.578313254
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -87.17393435702984
Rule of 40 score: 0
Financial ratios for HEMO.L — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -2142029.1139240507
Operating income: -7036136.70886076
Net income: -8469212.658227848
Capital expenditures: 148462.0253164557
Operating cash flow: -7728569.620253164
Depreciation & amortization: 817317.7215189873
Net tangible assets: 2972855.6962025315
Owner earnings: -7800356.9620253155
Return on net tangible assets (%): -262.3859937766015
Buffett classification: The Gruesome
Stock price: 0.11645569620253164
Shares outstanding: 6799961
Book value: 3520260.7594936714
P/B ratio: 0.2249532766200432
Market cap (USD): 791894.1924050633
Debt to equity: 1.0592878979764875
Current ratio: 2.9258890149058088
Quick ratio: 2.9258890149058088
Interest coverage ratio: -17.590842777167705
Free cash flow (dilution-adjusted): -8184418.987341772
Buyback yield (%): 0
Retained earnings: -30132574.683544304
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -103.61977268532931
Rule of 40 score: 0
Financial ratios for HEMO.L — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -1627115
Operating income: -7158367.5
Net income: -7023976.25
Capital expenditures: 16606.25
Operating cash flow: -5175073.75
Depreciation & amortization: 799106.25
Net tangible assets: 525138.75
Owner earnings: -6241476.25
Return on net tangible assets (%): -1188.53850529979
Buffett classification: The Gruesome
Stock price: 0.050624999999999996
Shares outstanding: 6799961
Book value: 1066867.5
P/B ratio: 0.32267177097905786
Market cap (USD): 344248.02562499995
Debt to equity: 3.0733502520228613
Current ratio: 0.7241581388042839
Quick ratio: 0.7241581388042839
Interest coverage ratio: -21.088523503525987
Free cash flow (dilution-adjusted): -5621598.75
Buyback yield (%): 0
Retained earnings: -36779893.75
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -187.5816721570621
Rule of 40 score: 0
Financial ratios for HEMO.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 525138.75
Buffett classification: The Gruesome
Stock price: 0.050624999999999996
Shares outstanding: 6799961
Book value: 1066867.5
P/B ratio: 0.32267177097905786
Market cap (USD): 344248.02562499995
Debt to equity: 3.0733502520228613
Current ratio: 0.7241581388042839
Quick ratio: 0.7241581388042839
Buyback yield (%): 0
Retained earnings: -36779893.75
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEMO.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -934482.1917808219
Buffett classification: The Gruesome
Stock price: 0.020958904109589043
Shares outstanding: 6799961
Book value: -748508.2191780824
Market cap (USD): 142519.73054794522
Debt to equity: -4.032396858774804
Current ratio: 0.43076472980675745
Quick ratio: 0.43076472980675745
Buyback yield (%): 0
Retained earnings: -47161761.64383562
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INSP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 230.06
Shares outstanding: 28813153
Market cap (USD): 6628753979.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INSP — annual report dated 2022-12-31
Total revenue: 407856000
Gross profit: 341741000
Operating income: -47592000
Net income: -44881000
Capital expenditures: 9096000
Operating cash flow: 11569000
Depreciation & amortization: 1858000
Net tangible assets: 496008000
Owner earnings: -52119000
Return on net tangible assets (%): -10.507693424299609
Buffett classification: The Gruesome
Stock price: 251.88
Shares outstanding: 28813153
Book value: 496008000
P/B ratio: 14.631733717278754
Market cap (USD): 7257456977.64
Debt to equity: 0.01788680827728585
Current ratio: 8.662635243356323
Quick ratio: 8.468375118491158
Interest coverage ratio: -28.379248658318424
COGS to revenue (%): 16.2103781726884
R&D to revenue (%): 16.830695147306894
SG&A to revenue (%): 78.62775097093092
Free cash flow (dilution-adjusted): -49497000
Buyback yield (%): 0
Retained earnings: -324270000
Inventory turnover: 5.562426383981155
Receivables turnover: 6.661266087410988
Capitalized R&D asset: 68645000
ROCI (R&D-adjusted, %): -0.3195098441763422
FCF margin (%): -12.135900906202188
Rule of 40 score: -12.135900906202188
Financial ratios for INSP — annual report dated 2023-12-31
Total revenue: 624799000
Gross profit: 528223000
Operating income: -40271000
Net income: -21153000
Capital expenditures: 23629000
Operating cash flow: 24653000
Depreciation & amortization: 2846000
Net tangible assets: 572514000
Owner earnings: -41936000
Return on net tangible assets (%): -7.324886378324373
Buffett classification: The Gruesome
Stock price: 203.43
Shares outstanding: 28813153
Book value: 572514000
P/B ratio: 10.23810721622528
Market cap (USD): 5861459714.79
Debt to equity: 0.04339806537482053
Current ratio: 7.60180526214711
Quick ratio: 7.167966199347033
COGS to revenue (%): 15.457131013333889
R&D to revenue (%): 18.65175840550321
SG&A to revenue (%): 72.33654343236785
Free cash flow (dilution-adjusted): -81446000
Buyback yield (%): 0
Retained earnings: -345423000
Inventory turnover: 2.850110668437362
Receivables turnover: 6.9511703974010945
Capitalized R&D asset: 162528150
ROCI (R&D-adjusted, %): 1.909793458425374
Rosenberg metric: 2.716614465729478
FCF margin (%): -13.035552233598324
Revenue growth (%): 53.191077242948495
Rule of 40 score: 40.15552500935017
Financial ratios for INSP — quarterly report dated 2024-12-31
Capital expenditures: 7027000
Buffett classification: The Gruesome
Stock price: 185.38
Shares outstanding: 28813153
Market cap (USD): 5341382303.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INSP — annual report dated 2024-12-31
Total revenue: 802804000
Gross profit: 679818000
Operating income: 36083000
Net income: 53509000
Capital expenditures: 39123000
Operating cash flow: 130246000
Depreciation & amortization: 6550000
Net tangible assets: 689695000
Owner earnings: 20936000
Return on net tangible assets (%): 3.035544697293731
Capex to operating income (%): 108.42502009256437
Buffett classification: The Gruesome
Stock price: 185.38
P/E ratio: 99.82212904632866
Shares outstanding: 28813153
Book value: 689695000
P/B ratio: 7.7445570913809725
Market cap (USD): 5341382303.14
Debt to equity: 0.046097187887399506
Current ratio: 7.127670873775438
Quick ratio: 6.222392967311104
Effective tax rate (%): 8.458077429729869
Interest coverage ratio: 1640.1363636363637
COGS to revenue (%): 15.319554959865672
R&D to revenue (%): 14.216172316032308
SG&A to revenue (%): 65.96965137194134
Free cash flow (dilution-adjusted): -24884000
Buyback yield (%): 1.4041309111296953
Retained earnings: -291914000
Inventory turnover: 1.5350607853416212
Receivables turnover: 8.625993896935574
Capitalized R&D asset: 214859970
ROCI (R&D-adjusted, %): 5.396284210211865
Rosenberg metric: 1.3008426580627446
FCF margin (%): -3.0996357766030065
Revenue growth (%): 28.4899623718988
Rule of 40 score: 25.390326595295797
Financial ratios for INSP — quarterly report dated 2025-03-31
Total revenue: 201317000
Gross profit: 170608000
Operating income: -1485000
Net income: 2992000
Capital expenditures: 8407000
Operating cash flow: -6703000
Depreciation & amortization: 3044000
Net tangible assets: 635743000
Owner earnings: -2371000
Return on net tangible assets (%): -0.37294944655308826
Buffett classification: The Gruesome
Stock price: 159.28
P/E ratio: 383.4691686029412
Shares outstanding: 28813153
Book value: 635743000
P/B ratio: 7.218890353240224
Market cap (USD): 4589359009.84
Debt to equity: 0.05273042723238793
Current ratio: 9.00707420828738
Quick ratio: 7.4358279502126985
Effective tax rate (%): 28.059629718682377
COGS to revenue (%): 15.254052067137897
R&D to revenue (%): 13.81055747900078
SG&A to revenue (%): 71.67303307718672
Free cash flow (dilution-adjusted): -46166000
Buyback yield (%): 1.6344112508778226
Retained earnings: -288922000
Inventory turnover: 0.30793065067634645
Receivables turnover: 2.173392494710023
Capitalized R&D asset: 27803000
ROCI (R&D-adjusted, %): 2.4527842272993627
FCF margin (%): -22.931992827232673
Rule of 40 score: -22.931992827232673
Financial ratios for INSP — quarterly report dated 2025-06-30
Total revenue: 217086000
Gross profit: 182414000
Operating income: -3316000
Net income: -3592000
Capital expenditures: 8997000
Operating cash flow: 2684000
Depreciation & amortization: 3414000
Net tangible assets: 677814000
Owner earnings: -9175000
Return on net tangible assets (%): -1.3536161837908334
Buffett classification: The Gruesome
Stock price: 129.77
Shares outstanding: 28813153
Book value: 677814000
P/B ratio: 5.516384826530583
Market cap (USD): 3739082864.8100004
Debt to equity: 0.04877296721519473
Current ratio: 6.1396223181482235
Quick ratio: 4.836769888280723
Interest coverage ratio: -829
COGS to revenue (%): 15.971550445445585
R&D to revenue (%): 12.073095455257365
SG&A to revenue (%): 73.48285932763974
Free cash flow (dilution-adjusted): -48037000
Buyback yield (%): 0
Retained earnings: -292514000
Inventory turnover: 0.28505422048292817
Receivables turnover: 1.5766630110322688
Capitalized R&D asset: 44837010
ROCI (R&D-adjusted, %): 0.648691529212461
Rosenberg metric: 0.4246304355645074
FCF margin (%): -22.128096699004082
Revenue growth (%): 7.832920220349002
Rule of 40 score: -14.29517647865508
Financial ratios for INSP — quarterly report dated 2025-09-30
Total revenue: 224501000
Gross profit: 192728000
Operating income: 9644000
Net income: 9932000
Capital expenditures: 10439000
Operating cash flow: 68526000
Depreciation & amortization: 3677000
Net tangible assets: 666460000
Owner earnings: 3170000
Return on net tangible assets (%): 0.47564745070972003
Capex to operating income (%): 108.2434674408959
Buffett classification: The Gruesome
Stock price: 74.2
P/E ratio: 229.09729453493355
Shares outstanding: 28813153
Book value: 666460000
P/B ratio: 3.2078983773969934
Market cap (USD): 2137935952.6000001
Debt to equity: 0.04887915253728656
Current ratio: 5.291168589807205
Quick ratio: 4.012089171170033
Effective tax rate (%): 26.706516124271275
Interest coverage ratio: 876.7272727272727
COGS to revenue (%): 14.152720923292101
R&D to revenue (%): 10.784361762308409
SG&A to revenue (%): 70.76716807497516
Free cash flow (dilution-adjusted): 28620000
Buyback yield (%): 2.3386575233554074
Retained earnings: -282582000
Inventory turnover: 0.224105461393597
Receivables turnover: 2.0789247052940576
Capitalized R&D asset: 50946020
ROCI (R&D-adjusted, %): 1.0404478167279922
Rosenberg metric: 0.3935289404403068
FCF margin (%): 12.748272836201174
Revenue growth (%): 3.415697004873645
Rule of 40 score: 16.16396984107482
Financial ratios for INSP — quarterly report dated 2025-12-31
Total revenue: 269077000
Gross profit: 233006000
Operating income: 46111000
Net income: 136090000
Capital expenditures: 10656000
Operating cash flow: 52469000
Depreciation & amortization: 3822000
Net tangible assets: 781160000
Owner earnings: 129256000
Return on net tangible assets (%): 16.546674176865174
Capex to operating income (%): 23.109453275791026
Buffett classification: The Great
Stock price: 92.23
P/E ratio: 18.273968871216187
Shares outstanding: 28813153
Book value: 781160000
P/B ratio: 3.4019113897152953
Market cap (USD): 2657437101.19
Debt to equity: 0.0411631419939577
Current ratio: 6.076227161522045
Quick ratio: 4.563625006506689
Effective tax rate (%): -170.45450028816154
Interest coverage ratio: 377.9590163934426
COGS to revenue (%): 13.405456430687126
R&D to revenue (%): 9.26946561764848
SG&A to revenue (%): 60.18834757337119
Free cash flow (dilution-adjusted): 13801000
Buyback yield (%): 1.8819260097484556
Retained earnings: -146492000
Inventory turnover: 0.24826385304178453
Receivables turnover: 2.248078401229823
Capitalized R&D asset: 49812340
ROCI (R&D-adjusted, %): 5.334305204511533
Rosenberg metric: 1.6636239725744497
FCF margin (%): 5.129015114632614
Revenue growth (%): 19.855590843693346
Rule of 40 score: 24.98460595832596
Financial ratios for INSP — annual report dated 2025-12-31
Total revenue: 911981000
Gross profit: 778756000
Operating income: 50954000
Net income: 145422000
Capital expenditures: 38499000
Operating cash flow: 116976000
Depreciation & amortization: 13957000
Net tangible assets: 781160000
Owner earnings: 120880000
Return on net tangible assets (%): 15.474422653489682
Capex to operating income (%): 75.55638418966126
Buffett classification: The Gruesome
Stock price: 92.23
P/E ratio: 18.273968871216187
Shares outstanding: 28813153
Book value: 781160000
P/B ratio: 3.4019113897152953
Market cap (USD): 2657437101.19
Debt to equity: 0.0411631419939577
Current ratio: 6.076227161522045
Quick ratio: 4.563625006506689
Effective tax rate (%): -121.35257317685739
Interest coverage ratio: 371.9270072992701
COGS to revenue (%): 14.608308725730032
R&D to revenue (%): 11.312187424957317
SG&A to revenue (%): 68.49232604626631
Free cash flow (dilution-adjusted): -51782000
Buyback yield (%): 6.5860072444095294
Retained earnings: -146492000
Inventory turnover: 0.9169402517671189
Receivables turnover: 7.619398121846071
Capitalized R&D asset: 218087640
ROCI (R&D-adjusted, %): 4.162110229782241
Rosenberg metric: 0.8669038272816487
FCF margin (%): -5.67796916821732
Revenue growth (%): 13.599458896567532
Rule of 40 score: 7.9214897283502115
Financial ratios for JSFB.NS — annual report dated 2024-03-31
Total revenue: 314769420.7938602
Net income: 80290238.63772635
Capital expenditures: 9153699.484350642
Operating cash flow: 84880645.16129032
Depreciation & amortization: 7424127.593236599
Net tangible assets: 428960163.0890994
Owner earnings: 78560666.74661231
Return on net tangible assets (%): 18.314210387479374
Buffett classification: The Gruesome
Stock price: 4.913627639155471
P/E ratio: 6.4695485955391225
Shares outstanding: 105714482
Book value: 428960163.0890994
P/B ratio: 1.210932028917357
Market cap (USD): 519441600.6142035
Debt to equity: 1.2332505604821427
Effective tax rate (%): -30.17195037094254
COGS to revenue (%): 0
SG&A to revenue (%): 9.660518559793347
Free cash flow (dilution-adjusted): 74358987.888236
Buyback yield (%): 6.233228708154028
Retained earnings: -410806859.33565176
Receivables turnover: 4.79418392039447
Capitalized R&D asset: 0
FCF margin (%): 23.623320111813868
Revenue growth (%): 16.65917657633545
Rule of 40 score: 40.28249668814932
Financial ratios for JSFB.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 461182919.2546584
Buffett classification: The Gruesome
Stock price: 6.923076923076923
Shares outstanding: 105714482
Book value: 461182919.2546582
P/B ratio: 1.5869397157033553
Market cap (USD): 731869490.7692308
Debt to equity: 0.9187333855578294
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JSFB.NS — quarterly report dated 2024-12-31
Total revenue: 89752931.57710688
Net income: 12898950.926681431
Capital expenditures: 0
Owner earnings: 12898950.926681431
Buffett classification: The Gruesome
Stock price: 4.603683412985196
P/E ratio: 9.432472649559324
Shares outstanding: 105714482
Market cap (USD): 486676007.295722
Effective tax rate (%): -5.0544970897861035
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JSFB.NS — quarterly report dated 2025-03-31
Total revenue: 95318026.65419686
Net income: 14435176.525602056
Capital expenditures: 0
Net tangible assets: 481452618.65793777
Owner earnings: 14435176.525602056
Return on net tangible assets (%): 2.998254857526895
Buffett classification: The Gruesome
Stock price: 4.750262574396079
P/E ratio: 8.697010849254642
Shares outstanding: 105714482
Book value: 481452618.657938
P/B ratio: 1.0430342009896727
Market cap (USD): 502171547.416268
Debt to equity: 0.81994503278343
Effective tax rate (%): -3.037421196026319
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: -357521159.69137245
Receivables turnover: 0.70461561674944
Capitalized R&D asset: 0
Revenue growth (%): 6.200460507865416
Rule of 40 score: 6.200460507865416
Financial ratios for JSFB.NS — annual report dated 2025-03-31
Total revenue: 365970797.28781855
Net income: 58618038.344634086
Capital expenditures: 8469710.077156885
Operating cash flow: 476180851.0638298
Depreciation & amortization: 7079728.781856441
Net tangible assets: 481452618.65793777
Owner earnings: 57228057.04933364
Return on net tangible assets (%): 11.886539782223721
Buffett classification: The Gruesome
Stock price: 4.750262574396079
P/E ratio: 8.566843272097264
Shares outstanding: 105714482
Book value: 481452618.657938
P/B ratio: 1.0430342009896727
Market cap (USD): 502171547.416268
Debt to equity: 0.81994503278343
Effective tax rate (%): -5.856446784524508
COGS to revenue (%): 0
SG&A to revenue (%): 9.1645391673994
Free cash flow (dilution-adjusted): 464781377.13350475
Buyback yield (%): 0
Retained earnings: -357521159.69137245
Receivables turnover: 2.7053512131420794
Capitalized R&D asset: 0
FCF margin (%): 126.99958045231034
Revenue growth (%): 16.266312135666347
Rule of 40 score: 143.26589258797668
Financial ratios for JSFB.NS — quarterly report dated 2025-06-30
Total revenue: 99646747.01614791
Net income: 11926632.34261643
Capital expenditures: 0
Owner earnings: 11926632.34261643
Buffett classification: The Gruesome
Stock price: 5.995787502925346
P/E ratio: 16.144404065663654
Shares outstanding: 105714482
Market cap (USD): 633841570.0538265
Effective tax rate (%): 0
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.54134492067819
Rule of 40 score: 4.54134492067819
Financial ratios for JSFB.NS — quarterly report dated 2025-12-31
Total revenue: 102428483.90330847
Net income: 1079893.0600423305
Capital expenditures: 0
Owner earnings: 1079893.0600423305
Buffett classification: The Gruesome
Stock price: 4.737662916341763
P/E ratio: 12.415257206981952
Shares outstanding: 105714482
Market cap (USD): 500839581.0916788
Effective tax rate (%): 0
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.7915982914221673
Rule of 40 score: 2.7915982914221673
Financial ratios for JUSTDIAL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.38151127522089
Shares outstanding: 85049032
Market cap (USD): 797888452.6546222
Buyback yield (%): 0
Retained earnings: 154227878.14849004
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JUSTDIAL.NS — annual report dated 2023-03-31
Total revenue: 102894031.66869672
Operating income: 6624847.746650427
Net income: 19819732.034104753
Capital expenditures: 2151035.3227771013
Operating cash flow: 21775883.069427527
Depreciation & amortization: 3917174.1778319124
Net tangible assets: 442500609.01339835
Owner earnings: 21585870.889159568
Return on net tangible assets (%): 4.878156198990898
Capex to operating income (%): 32.46920389777533
Buffett classification: The Good
Stock price: 7.2496954933008535
P/E ratio: 31.10938043657817
Shares outstanding: 85049032
Book value: 446661388.5505482
P/B ratio: 1.3804183656905065
Market cap (USD): 616579584.0000001
Debt to equity: 0.018646938035335917
Current ratio: 7.754410713613964
Quick ratio: 7.754410713613964
Effective tax rate (%): 13.368471490177287
Interest coverage ratio: 7.091264667535854
COGS to revenue (%): 0
SG&A to revenue (%): 5.03456603058857
Free cash flow (dilution-adjusted): 14520097.442143727
Buyback yield (%): 0
Retained earnings: 163244823.3861145
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4294650084627272
FCF margin (%): 14.111700364600596
Rule of 40 score: 14.111700364600596
Financial ratios for JUSTDIAL.NS — annual report dated 2024-03-31
Total revenue: 125064156.3736659
Operating income: 20506055.88200024
Net income: 43512411.560139105
Capital expenditures: 1307111.1644082025
Operating cash flow: 31085262.021825157
Depreciation & amortization: 5536635.088140065
Net tangible assets: 479160570.8118479
Owner earnings: 47741935.48387097
Return on net tangible assets (%): 9.963661117395613
Capex to operating income (%): 6.374269005847953
Buffett classification: The Great
Stock price: 9.63471689059501
P/E ratio: 18.831945087819808
Shares outstanding: 85049032
Book value: 482501498.98069316
P/B ratio: 1.698281449633266
Market cap (USD): 819423345.1391555
Debt to equity: 0.021202511196496653
Current ratio: 7.67977123004818
Quick ratio: 7.67977123004818
Effective tax rate (%): 22.216982143239942
Interest coverage ratio: 18.426724137931036
COGS to revenue (%): 0
SG&A to revenue (%): 3.81912149658168
Free cash flow (dilution-adjusted): 29360834.632449932
Buyback yield (%): 0
Retained earnings: 203998081.3047128
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.022819502440746
FCF margin (%): 23.47661830838711
Revenue growth (%): 21.546560422817958
Rule of 40 score: 45.023178731205064
Financial ratios for JUSTDIAL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 513124701.38557094
Buffett classification: The Gruesome
Stock price: 13.79120879120879
Shares outstanding: 85049032
Book value: 515735785.9531773
P/B ratio: 2.2742826651720573
Market cap (USD): 1172928957.8021977
Debt to equity: 0.02165253118529601
Current ratio: 8.27516578742827
Quick ratio: 8.27516578742827
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JUSTDIAL.NS — quarterly report dated 2024-12-31
Total revenue: 33492248.513812795
Operating income: 8694486.53689241
Net income: 15305979.71791584
Capital expenditures: 0
Depreciation & amortization: 1399930.061778762
Owner earnings: 16705909.779694602
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.580603799976686
P/E ratio: 16.087162686010203
Shares outstanding: 85049032
Market cap (USD): 984919143.1635387
Effective tax rate (%): 11.97291680632835
Interest coverage ratio: 26.356890459363957
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JUSTDIAL.NS — quarterly report dated 2025-03-31
Total revenue: 33808744.447042316
Operating income: 8682487.725040916
Net income: 18424129.062426932
Capital expenditures: 0
Depreciation & amortization: 1380640.6359597847
Net tangible assets: 536558335.2817395
Owner earnings: 19804769.698386718
Return on net tangible assets (%): 3.6910748368092174
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.51803010853075
P/E ratio: 10.984226778570495
Shares outstanding: 85049032
Book value: 538519990.6476502
P/B ratio: 1.5031925672877107
Market cap (USD): 809499247.2773952
Debt to equity: 0.021673721914685768
Current ratio: 8.18236687294675
Quick ratio: 8.18236687294675
Effective tax rate (%): 12.21522865259288
Interest coverage ratio: 21.908554572271388
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 267166238.01730183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5262547881697275
Revenue growth (%): 0.9449826370988272
Rule of 40 score: 0.9449826370988272
Financial ratios for JUSTDIAL.NS — annual report dated 2025-03-31
Total revenue: 133496609.7732055
Operating income: 33682487.72504091
Net income: 68295534.25298105
Capital expenditures: 592705.1671732522
Operating cash flow: 36414542.9039046
Depreciation & amortization: 5524900.631283609
Net tangible assets: 536558335.2817395
Owner earnings: 73227729.71709141
Return on net tangible assets (%): 13.647673496422442
Capex to operating income (%): 1.759683465222824
Buffett classification: The Great
Stock price: 9.51803010853075
P/E ratio: 11.852886958594384
Shares outstanding: 85049032
Book value: 538519990.6476502
P/B ratio: 1.5031925672877107
Market cap (USD): 809499247.2773952
Debt to equity: 0.021673721914685768
Current ratio: 8.18236687294675
Quick ratio: 8.18236687294675
Effective tax rate (%): 12.037943235714824
Interest coverage ratio: 27.413891531874402
COGS to revenue (%): 0
SG&A to revenue (%): 3.793577539779146
Free cash flow (dilution-adjusted): 35655833.52817395
Buyback yield (%): 0
Retained earnings: 267166238.01730183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.920890394068423
FCF margin (%): 26.7091678123878
Revenue growth (%): 6.74250212374613
Rule of 40 score: 33.45166993613393
Financial ratios for JUSTDIAL.NS — quarterly report dated 2025-06-30
Total revenue: 34853732.740463376
Operating income: 8744441.844137609
Net income: 18681254.38801779
Capital expenditures: 0
Depreciation & amortization: 1370231.687339106
Owner earnings: 20051486.075356893
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.870582728761995
P/E ratio: 17.639925437299894
Shares outstanding: 85049032
Market cap (USD): 924532538.3571262
Effective tax rate (%): 19.737569755165655
Interest coverage ratio: 23.875399361022364
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.09088169499438
Rule of 40 score: 3.09088169499438
Financial ratios for JUSTDIAL.NS — quarterly report dated 2025-12-31
Total revenue: 34052578.81252089
Operating income: 9365044.00133675
Net income: 13136905.424974937
Capital expenditures: 0
Depreciation & amortization: 1244290.9658014928
Owner earnings: 14381196.39077643
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.079536593516766
P/E ratio: 10.483217650649644
Shares outstanding: 85049032
Market cap (USD): 687156766.2871784
Effective tax rate (%): 19.01524515863206
Interest coverage ratio: 42.035
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.2986172927538013
Rule of 40 score: -2.2986172927538013
Financial ratios for L1M.AX — annual report dated 2023-06-30
Operating income: -1444088.0794701986
Net income: -1441375.4966887417
Capital expenditures: 3235.099337748344
Depreciation & amortization: 25509.271523178806
Net tangible assets: 4298631.78807947
Owner earnings: -1419101.3245033112
Return on net tangible assets (%): -33.012860706949105
Buffett classification: The Gruesome
Stock price: 0.10596026490066225
Shares outstanding: 339828319
Book value: 4298631.788079469
P/B ratio: 8.376688322512601
Market cap (USD): 36008298.70198675
Debt to equity: 0.013715745684673425
Current ratio: 12.070156144129932
Quick ratio: 12.070156144129932
Interest coverage ratio: -316.5296850050805
Free cash flow (dilution-adjusted): -1481616.5562913907
Buyback yield (%): 0.7639795169630933
Retained earnings: -1480139.072847682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.49285875671851
Rule of 40 score: 0
Financial ratios for LFS — annual report dated 2025-12-31
Total revenue: 74984988.90096541
Gross profit: 22157270.967329454
Operating income: 4118836.2700594594
Net income: 2803270.99929672
Capital expenditures: 272349.68991752446
Operating cash flow: 2994028.533981203
Depreciation & amortization: 806272.7766766831
Net tangible assets: 11438423.764465189
Owner earnings: 3337194.086055879
Return on net tangible assets (%): 29.175296830873375
Capex to operating income (%): 6.612297067918964
Buffett classification: The Great
Stock price: 2.77
P/E ratio: 25.850128171047277
Shares outstanding: 26160619
Book value: 11806884.917844128
P/B ratio: 6.137513419859071
Market cap (USD): 72464914.63
Debt to equity: 0.5701368517165837
Current ratio: 1.5435984657179593
Quick ratio: 1.5340077764814415
Effective tax rate (%): 27.7442805463665
Interest coverage ratio: 39.08945324644782
COGS to revenue (%): 70.45105788227411
SG&A to revenue (%): 19.629791710942698
Free cash flow (dilution-adjusted): 2651990.205229845
Buyback yield (%): 0
Retained earnings: 4795008.394603926
Inventory turnover: 382.91781954769095
Receivables turnover: 16.042493447578067
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.563215740121233
FCF margin (%): 3.536694802652297
Revenue growth (%): 13.962081377650565
Rule of 40 score: 17.498776180302862
Financial ratios for LFS — quarterly report dated 2025-12-31
Total revenue: 20281987.878012914
Gross profit: 6743061.684035548
Operating income: 1749048.0531935298
Net income: 1353956.5884534237
Capital expenditures: 0
Operating cash flow: 905052.669266671
Depreciation & amortization: 191009.59017965605
Net tangible assets: 11438423.764465189
Owner earnings: 1544966.1786330799
Return on net tangible assets (%): 13.5068101204005
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.77
P/E ratio: 25.3307939952817
Shares outstanding: 26160619
Book value: 11806884.917844128
P/B ratio: 6.137513419859071
Market cap (USD): 72464914.63
Debt to equity: 0.5701368517165837
Current ratio: 1.5435984657179593
Quick ratio: 1.5340077764814415
Effective tax rate (%): 19.377977677126346
Interest coverage ratio: 92.21372241023636
COGS to revenue (%): 66.7534478149181
SG&A to revenue (%): 7.788659400975188
Free cash flow (dilution-adjusted): 872957.5346844831
Buyback yield (%): 0
Retained earnings: 4795008.394603926
Inventory turnover: 98.13590857223147
Receivables turnover: 4.339183914084582
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.279967867270448
FCF margin (%): 4.304102437763657
Revenue growth (%): -1.7403717106354994
Rule of 40 score: 2.5637307271281573
Financial ratios for LHAI — quarterly report dated 2025-09-30
Total revenue: 5407677
Gross profit: 206097
Operating income: 9424
Net income: -305
Capital expenditures: 303650
Operating cash flow: -3107578
Depreciation & amortization: 10831
Net tangible assets: 7200109
Owner earnings: -293124
Return on net tangible assets (%): -4.071105034659892
Capex to operating income (%): 3222.0925297113754
Buffett classification: The Gruesome
Stock price: 9.06
P/E ratio: 1580.7329378733825
Shares outstanding: 16530000
Book value: 7202983
P/B ratio: 20.79163590973351
Market cap (USD): 149761800
Debt to equity: 0.06104137688510441
Current ratio: 5.7957845322335455
Quick ratio: 5.7957845322335455
Effective tax rate (%): 103.49249971372953
Interest coverage ratio: 15.2987012987013
COGS to revenue (%): 96.18880713474566
SG&A to revenue (%): 3.3743509458867456
Free cash flow (dilution-adjusted): -3412653
Buyback yield (%): 0
Retained earnings: 1253232
Receivables turnover: 451.35439445789166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.12521270148927913
FCF margin (%): -63.10755986350516
Revenue growth (%): 12.670359508254514
Rule of 40 score: -50.437200355250646
Financial ratios for LHAI — annual report dated 2025-12-31
Total revenue: 20994347
Gross profit: 773017
Operating income: 76432
Net income: 74874
Capital expenditures: 303650
Operating cash flow: 524430
Depreciation & amortization: 47002
Net tangible assets: 7074683
Owner earnings: -181774
Return on net tangible assets (%): -2.569358938061253
Capex to operating income (%): 397.2812434582374
Buffett classification: The Gruesome
Stock price: 7.64
P/E ratio: 1686.6896385928358
Shares outstanding: 16530000
Book value: 7639436
P/B ratio: 16.53122036757687
Market cap (USD): 126289200
Debt to equity: 0.053849263217860585
Current ratio: 3.431846042520867
Quick ratio: 3.431846042520867
Effective tax rate (%): 40.67365518552853
Interest coverage ratio: 15.623875715453803
COGS to revenue (%): 96.31797550073836
SG&A to revenue (%): 3.0156403530912392
Free cash flow (dilution-adjusted): -350645
Buyback yield (%): 0
Retained earnings: 1233364
Receivables turnover: 163.7177603618357
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9635331836027913
FCF margin (%): -1.6701876938587328
Revenue growth (%): 175.68615421545053
Rule of 40 score: 174.0159665215918
Financial ratios for LHAI — quarterly report dated 2025-12-31
Total revenue: 5077688
Gross profit: 195461
Operating income: -70088
Net income: -19868
Capital expenditures: 0
Operating cash flow: 2823425
Depreciation & amortization: 26764
Net tangible assets: 7074683
Owner earnings: 6896
Buffett classification: The Gruesome
Stock price: 7.64
P/E ratio: 1686.6896385928358
Shares outstanding: 16530000
Book value: 7639436
P/B ratio: 16.53122036757687
Market cap (USD): 126289200
Debt to equity: 0.053849263217860585
Current ratio: 3.431846042520867
Quick ratio: 3.431846042520867
Interest coverage ratio: -23.78282999660672
COGS to revenue (%): 96.15059058374598
SG&A to revenue (%): 4.613438241971543
Free cash flow (dilution-adjusted): 2253425
Buyback yield (%): 0
Retained earnings: 1233364
Receivables turnover: 39.59674035949624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8835581140406168
FCF margin (%): 44.3789575097958
Revenue growth (%): -6.1022320674848
Rule of 40 score: 38.276725442311
Financial ratios for MAW.L — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 211.79394736842107
Shares outstanding: 12339847
Market cap (USD): 2613504906.0523686
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAW.L — annual report dated 2023-03-31
Total revenue: 441471471.4714715
Gross profit: 228288288.2882883
Operating income: 151216216.21621624
Net income: 112762762.76276277
Capital expenditures: 65292792.7927928
Operating cash flow: 117469969.96996997
Depreciation & amortization: 23175675.67567568
Net tangible assets: 705172672.6726727
Owner earnings: 70645645.64564565
Return on net tangible assets (%): 10.01820524012818
Capex to operating income (%): 43.17843312481382
Buffett classification: The Good
Stock price: 216.8953086419753
P/E ratio: 23.735272691842816
Shares outstanding: 12339847
Book value: 707304804.8048048
P/B ratio: 3.7840191463118584
Market cap (USD): 2676454923.659753
Debt to equity: 0.007780242641673655
Current ratio: 5.781099922540666
Quick ratio: 5.08869093725794
Effective tax rate (%): 29.025704025704023
Interest coverage ratio: 4028.3999999999996
COGS to revenue (%): 48.28923202503231
Free cash flow (dilution-adjusted): 51974474.47447448
Buyback yield (%): 0.0005610038443869498
Retained earnings: 550908408.4084084
Inventory turnover: 3.1766416825148225
Receivables turnover: 5.324520101412531
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.175134828271364
FCF margin (%): 11.773008638868106
Rule of 40 score: 11.773008638868106
Financial ratios for MAW.L — annual report dated 2024-03-31
Total revenue: 406524035.92181724
Gross profit: 204661912.30850503
Operating income: 130758055.99577391
Net income: 100475435.81616482
Capital expenditures: 74234020.07395668
Operating cash flow: 113721605.9165346
Depreciation & amortization: 27324352.879028
Net tangible assets: 718984416.2704701
Owner earnings: 53565768.62123613
Return on net tangible assets (%): 7.450198837284057
Capex to operating income (%): 56.77204322795677
Buffett classification: The Good
Stock price: 402.6759493670886
P/E ratio: 49.45447178612981
Shares outstanding: 12339847
Book value: 721084257.7918648
P/B ratio: 6.890955602034334
Market cap (USD): 4968959605.76962
Debt to equity: 0.003662970119321252
Current ratio: 6.511582559862726
Quick ratio: 5.748537555572889
Effective tax rate (%): 27.598020555767032
Interest coverage ratio: 19802
COGS to revenue (%): 49.6556429081931
Free cash flow (dilution-adjusted): 38946117.274167985
Buyback yield (%): 0.0006644524959353745
Retained earnings: 578268621.2361331
Inventory turnover: 3.1248083409996936
Receivables turnover: 4.299162011173185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.052035662843913
FCF margin (%): 9.58027418621272
Revenue growth (%): -7.916125459516267
Rule of 40 score: 1.6641487266964523
Financial ratios for MAW.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 519.0326666666666
Shares outstanding: 12339847
Market cap (USD): 6404783694.668666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAW.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 556.248875
Shares outstanding: 12339847
Market cap (USD): 6864026011.422125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0